A group of investors, including Elliott Investment Management, Patient Square Capital, and Veritas Capital, is close to acquiring Syneos Health Inc (NASDAQ: SYNH) for more than $7 billion, including debt.
Bloomberg News first reported the news of the investment consortium’s talks with Syneos.
The consortium will pay about $43 per share in cash for Syneos, representing a 14% gain to Syneos’ value on February 24, the last trading …